Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Assessing Fracture Risk and Effects of Osteoporosis Drugs: Bone Mineral Density and Beyond
American Journal of Medicine, 10/27/09
Davison SK et al. – Although there have been numerous advances in the assessment of bone strength and fracture risk, the majority of these techniques can only be performed in research laboratories, making them largely unavailable to practicing clinicians. Prospective epidemiologic studies have identified risk factors that can be assessed within the clinic and combined with bone mineral density to allow clinicians to better identify untreated individuals at heightened risk for fracture and to make informed treatment decisions based on 10–year absolute fracture risk. This article discusses the assessment of fracture risk in clinical practice, reviews currently and soon–available bone measurement tools, and details the impacts of osteoporosis therapies on fracture risk.
Related Articles
Osteologix to Continue Development of Osteoporosis Drug
Internet Source, 10/21/09
Relevance Score: 93%
Lifestyle increases osteoporosis risk: docs
Internet Source, 10/21/09
Relevance Score: 90%
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/12/09
Relevance Score: 89%
A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts
Bone, 10/27/09
Relevance Score: 89%
Evaluation of Compliance with Osteoporosis Treatment Guidelines After Initiation of a Pharmacist-Run Osteoporosis Service at a Family Medicine Clinic
Annals of Pharmacotherapy, 10/15/09
Relevance Score: 89%
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Vitiligo therapy
Expert Opinion in Pharmacotherapy, 12/01/09
Biphasic insulin aspart in the treatment of type 2 diabetes mellitus
Expert Opinion in Pharmacotherapy, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


